Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland.

Daa T, Kaku N, Kashima K, Nakayama I, Yokoyama S.

J Exp Clin Cancer Res. 2005 Mar;24(1):83-7.

PMID:
15943036
2.

Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.

Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SO.

J Oral Pathol Med. 2009 Oct;38(9):701-7. doi: 10.1111/j.1600-0714.2009.00776.x. Epub 2009 Jul 31.

PMID:
19659475
3.

[Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].

Yang JF, Chen SL, Liu ZH, Zhang Y.

Ai Zheng. 2004 Jul;23(7):799-802. Chinese.

PMID:
15248915
4.

The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.

Zhang ZY, Wu YQ, Zhang WG, Tian Z, Cao J.

Chin J Dent Res. 2000 Nov;3(3):36-9.

PMID:
11314533
5.
6.

Beta-catenin and E-cadherin expression in salivary gland tumors.

Furuse C, Cury PR, Altemani A, dos Santos Pinto D Jr, de Araújo NS, de Araújo VC.

Int J Surg Pathol. 2006 Jul;14(3):212-7.

PMID:
16959701
7.

beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.

Saito T, Oda Y, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y, Tsuneyoshi M.

J Pathol. 2001 Sep;195(2):222-8.

PMID:
11592102
8.

Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.

Lim SC, Lee MS.

Oncol Rep. 2002 Sep-Oct;9(5):915-28.

PMID:
12168049
9.

Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.

Ueta T, Ikeguchi M, Hirooka Y, Kaibara N, Terada T.

Oncol Rep. 2002 Nov-Dec;9(6):1197-203.

PMID:
12375019
10.

Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.

Shiina H, Igawa M, Shigeno K, Terashima M, Deguchi M, Yamanaka M, Ribeiro-Filho L, Kane CJ, Dahiya R.

J Urol. 2002 Nov;168(5):2220-6.

PMID:
12394763
11.

Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.

Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ.

Chin Med J (Engl). 2004 Aug;117(8):1232-9.

PMID:
15361301
12.

beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.

Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K, Nabais S, Lopes C, Machado JC, Seruca R, Carneiro F, Huntsman DG.

Genes Chromosomes Cancer. 2005 Mar;42(3):238-46.

PMID:
15609344
13.

Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.

Zhang CY, Mao L, Li L, Tian Z, Zhou XJ, Zhang ZY, Li J.

Cancer. 2007 Jul 1;110(1):87-95.

14.

Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.

Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N.

Hum Pathol. 2005 Mar;36(3):234-41.

PMID:
15791567
15.

Ultrastructural localization of E-cadherin and alpha-/beta-catenin in adenoid cystic carcinoma.

Shibuya Y, Ri S, Umeda M, Yoshikawa T, Masago H, Komori T.

Histopathology. 1999 Nov;35(5):423-31.

PMID:
10583557
16.

Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.

Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, Ozaki T, Furuuchi K, Tada M, Ohnuma N, Nakagawara A.

Clin Cancer Res. 2001 Apr;7(4):901-8.

17.

[Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].

Bae SH, Jung ES, Park YM, Jang JW, Choi JY, Cho SH, Yoon SK, Ahn BM, Cha SB, Chung KW, Sun HS, Park DH, Kim BK, Kim DG.

Taehan Kan Hakhoe Chi. 2002 Sep;8(3):297-303. Korean.

18.

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K.

Clin Cancer Res. 2002 Feb;8(2):450-6.

19.

Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.

Wong NA, Morris RG, McCondochie A, Bader S, Jodrell DI, Harrison DJ.

J Pathol. 2002 May;197(1):128-35.

PMID:
12081197
20.

Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.

Kim HS, Hong EK, Park SY, Kim WH, Lee HS.

Anticancer Res. 2003 May-Jun;23(3C):2863-8.

PMID:
12926124

Supplemental Content

Support Center